Home › Pozen buying Canada's Tribute Pharmaceuticals for US$146 million
 

Keywords :   


Pozen buying Canada's Tribute Pharmaceuticals for US$146 million

2015-06-08 22:49:01| Biotech - Topix.net

U.S. specialty drug company Pozen Inc. announced Monday that it plans to acquire Tribute Pharmaceuticals Canada in a deal valued at about US$146 million. After the acquisition, expected to be competed in the fourth quarter, the combined company will change its name to Aralez Pharmaceuticals PLC and move its headquarters to Ireland to benefit from lower corporate tax rates in that country.

Tags: million buying tribute pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »